NUVB.WS icon

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50

20 hedge funds and large institutions have $2.34M invested in Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

Holders
20
Holders Change
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
EC
1
EcoR1 Capital
California
$1.85M 963,333
6CM
2
683 Capital Management
New York
$121K 835,323
HCM
3
Highbridge Capital Management
New York
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$38.5K 266,666
BC
5
Boxer Capital
California
$38.5K 266,666
Franklin Resources
6
Franklin Resources
California
$38.5K 266,666
CCA
7
Castle Creek Arbitrage
Colorado
$28.8K 215,426
DM
8
Deerfield Management
New York
$24.1K 166,666
BlackRock
9
BlackRock
New York
$22.5K 155,902
RSCM
10
Rock Springs Capital Management
Maryland
$19.4K 134,028
SB
11
Samsara BioCapital
California
$19.3K 133,333
GC
12
Greenlight Capital
New York
$14.5K 100,000
APM
13
Avidity Partners Management
Texas
$14.5K 99,999
ACP
14
Acuta Capital Partners
California
$13.1K 90,832
Citadel Advisors
15
Citadel Advisors
Florida
$10.7K 73,722 +296 +0.4%
LGM
16
Logos Global Management
California
$9.63K 66,666
Victory Capital Management
17
Victory Capital Management
Texas
$9.26K 64,051
CC
18
Clearline Capital
New York
$4.81K 33,271
IP
19
Intellectus Partners
California
$1.87K 12,972 -7,037 -35%
UBS Group
20
UBS Group
Switzerland
$71 505 -1,660 -77%
Barclays
21
Barclays
United Kingdom
$0 1,638 -280 -15%
CFGS
22
Concourse Financial Group Securities
Alabama